EMFAT
SRPT icon

Emerald Mutual Fund Advisers Trust’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,386
Closed -$1.36M 232
2025
Q1
$1.36M Buy
21,386
+2,286
+12% +$146K 0.1% 123
2024
Q4
$2.32M Buy
19,100
+18,082
+1,776% +$2.2M 0.14% 115
2024
Q3
$127K Buy
+1,018
New +$127K 0.01% 211
2023
Q1
Sell
-2,097
Closed -$272K 263
2022
Q4
$272K Sell
2,097
-432
-17% -$56K 0.02% 167
2022
Q3
$280K Buy
+2,529
New +$280K 0.02% 175
2021
Q1
Sell
-1,287
Closed -$219K 243
2020
Q4
$219K Hold
1,287
0.01% 209
2020
Q3
$181K Sell
1,287
-21
-2% -$2.95K 0.01% 242
2020
Q2
$210K Buy
+1,308
New +$210K 0.01% 231
2020
Q1
Sell
-1,767
Closed -$228K 301
2019
Q4
$228K Buy
+1,767
New +$228K 0.01% 207
2019
Q2
Sell
-40,842
Closed -$4.87M 215
2019
Q1
$4.87M Sell
40,842
-15,450
-27% -$1.84M 0.2% 145
2018
Q4
$6.14M Sell
56,292
-159,602
-74% -$17.4M 0.29% 123
2018
Q3
$34.9M Sell
215,894
-28,091
-12% -$4.54M 1.18% 11
2018
Q2
$32.3M Sell
243,985
-82,757
-25% -$10.9M 1.17% 12
2018
Q1
$24.2M Sell
326,742
-374,486
-53% -$27.7M 0.95% 21
2017
Q4
$39M Sell
701,228
-15,544
-2% -$865K 1.55% 4
2017
Q3
$32.5M Buy
716,772
+38,502
+6% +$1.75M 1.36% 8
2017
Q2
$22.9M Buy
678,270
+73,803
+12% +$2.49M 1% 24
2017
Q1
$17.9M Buy
604,467
+201,942
+50% +$5.98M 0.82% 39
2016
Q4
$11M Buy
402,525
+136,230
+51% +$3.74M 0.53% 72
2016
Q3
$16.4M Buy
266,295
+19,209
+8% +$1.18M 0.83% 39
2016
Q2
$4.71M Buy
+247,086
New +$4.71M 0.26% 121
2015
Q4
Sell
-322,970
Closed -$10.4M 294
2015
Q3
$10.4M Buy
322,970
+59,450
+23% +$1.91M 0.68% 56
2015
Q2
$8.02M Buy
+263,520
New +$8.02M 0.62% 65
2014
Q4
Sell
-217,693
Closed -$4.59M 224
2014
Q3
$4.59M Sell
217,693
-5,740
-3% -$121K 0.44% 84
2014
Q2
$6.66M Buy
223,433
+41,579
+23% +$1.24M 0.61% 63
2014
Q1
$4.37M Sell
181,854
-250,564
-58% -$6.02M 0.42% 87
2013
Q4
$9.73M Buy
432,418
+253,584
+142% +$5.7M 0.58% 69
2013
Q3
$8.45M Buy
178,834
+800
+0.4% +$37.8K 1.17% 21
2013
Q2
$6.77M Buy
+178,034
New +$6.77M 1.15% 27